下一代治疗方法:免疫疗法和COVID-19的先进疗法
Jenny Andrea Arevalo-Romero1,2, Sandra M Chingaté-López1, Bernardo Armando Camacho1
1Laboratorio de Investigación en Ingeniería Celular y Molecular, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, IDCBIS, 111611, Bogotá, DC, Colombia.
下一代疫苗和免疫疗法对于对抗不断演变的SARS-CoV-2变种至关重要,提供了增强的保护,并应对免疫功能低下的个人和老年人的挑战. 这些先进的治疗方法旨在改善适应性免疫力,促进组织修复.
科学领域:
- 病毒学和免疫学 病毒学和免疫学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 由SARS-CoV-2引起的COVID-19大流行突显了新出现的冠状病毒的威胁.
- 以前的SARS和MERS等疫情为SARS-CoV-2的缓解策略提供了信息.
- 持续的SARS-CoV-2的演变,包括像Omicron (B.1.1.529) 和JN.1这样的变种,由于免疫逃避,造成了持续的全球健康挑战.
研究的目的:
- 审查和分析下一代COVID-19治疗方法的进展情况.
- 讨论免疫治疗和先进疗法作为对现有选择的补充.
- 解决对不断演变的SARS-CoV-2变种进行更好的保护的需求,特别是针对脆弱人群.
主要方法:
- 审查有关SARS-CoV-2演变和治疗策略的当前科学文献.
- 对新兴免疫治疗方法和先进疗法的分析.
- 讨论突变对病毒感染性和免疫反应的影响.
主要成果:
- 下一代治疗的目的是引起强大的适应性免疫力,而不会引起急性炎症.
- 在Spike蛋白中的关键突变,特别是在Omicron血统中,有助于免疫逃避.
- 新兴疗法在向病毒,调节免疫反应和促进组织修复方面显示出潜力.
结论:
- 下一代疫苗对于持续保护不断演变的SARS-CoV-2变种至关重要.
- 先进的疗法为免疫功能低下的个体,老年人和慢性后COVID-19综合征提供了潜在的解决方案.
- 这些新型治疗方法对于管理冠状病毒感染及其并发症的长期影响至关重要.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
相关概念视频
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Gene Therapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
